Skip to content
VICT3R
VICT3R
  • About
    • Project
    • VICT3R Community
    • Work Packages
    • Facts & Figures
  • Results
    • Publications
    • Related Publications
    • Public Deliverables
    • Public IT Tools
  • News
    • Latest News
    • Minds Behind VICT3R
    • Newsletters
    • Training
  • Contact us

Leveraging biomarkers and translational medicine for preclinical safety – Lessons for advancing the validation of alternatives to animal testing

Leveraging biomarkers and translational medicine for preclinical safety – Lessons for advancing the validation of alternatives to animal testing
By VICT3R|2025-04-02T09:17:39+02:00April 2nd, 2025|

Follow us

Get involved!

Subscribe to our Newsletter

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101172693.
The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe and Instem Scientific Limited.
Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

  • About IHI
  • Privacy Policy
  • Disclaimer
  • Legal Notice
  • Cookies Policy

© 2025 | VICT3R – Developing and implementing Virtual Control Groups to reduce animal use in Toxicology Research

Page load link

Contact us

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.